isabelobrien, Author at European Medical Journal - Page 7 of 68

Lundbeck and Contera partner on RNA-targeted drug discovery

Lundbeck is partnering with Contera Pharma to accelerate RNA-targeted drug discovery for serious neurological conditions.

ViiV's bi-monthly HIV injection approved by NICE

Injectable HIV PrEP marks a breakthrough in prevention, providing a new option for patients in England unable to take daily pills.

Roche breaks world record for human genome sequencing

Roche has set a new Guinness World Record for the fastest DNA sequencing of a human genome, marking a major milestone in genomic innovation.

Inside the rise of HCP podcast engagement

HCP podcast engagement is growing fast. Explore EMJ data on audience trends, popular topics and how pharma can harness this powerful channel.

AstraZeneca to offer up to 80% off US drug prices

AstraZeneca joins Trump’s drug pricing plan, pledging $50bn US investment and discounts of up to 80% to cut prescription medicine costs.

Child using VR headset

NIHR funds £1.5m in innovative digital health projects

The UK’s NIHR has invested £1.5M in digital health to cut paediatric mental health waiting times.

Almirall’s Dr Volker Koscielny on World Mental Health Day

On World Mental Health Day, our latest Catalyst Dr Volker Koscielny calls for a new approach in dermatology.

Could the brain be a target for autoimmune disease?

A new biotech company in New York, Nilo Therapeutics, believes the brain could hold the key to treating immune diseases.

ABPI calls for NICE cost-effectiveness threshold review

ABPI calls for NICE to raise its cost effectiveness threshold for new medicine, which hasn’t raised in 20 years and is not linked to inflation.

Potential breakthrough in brain-computer interface research

New research from Precision Neuroscience shows its brain-computer interface can record high-resolution signals without invasive surgery.